Inc. of industry of 3 general drug conferences of 5 12 board of directorses were held on October 22, 2008, discuss and pass about agreeing

Sign " stock of travel of blame fair development buys asset framework agreement " second reading reach a company to issue share to buy asset and major asset to recombine to specific target (correlation trades) beforehand case.

Basis beforehand case, industry of 3 general drug will to accuse a partner far east to accuse a blame of group limited company to issue share publicly, the far east cable that buys far east to accuse a hold 100% equity, far east is compound technology 100% equity and cable of new far east 100% equity. Issue the price traded 20 times a few days ago for announcement of resolution of company board of directors day of company stock

Trade all valence, namely 7.19 yuan / , predicting blame issues share amount publicly to make an appointment with 333.8 million.

This second trade the value of face of net assets Zhang of mark makes an appointment with 980 million yuan, future prices is worth about 2.4 billion yuan, use at subscribe to be not the total share that issues publicly. This second issue after finishing, far east accuses hold a scale to reach farther promotion about 80.95% .

Through this second trade, the core business of the company is change the production of wire cable and medicine and sale, become have power cable, electric equipment cable, naked lead, carbon fiber the product of cable of 4 kinds of big wire such as compound lead and production of natural plant drug sell appear on the market company, ensure far east cable is gotten mediumly in the industry further thereby army position and enhance industry of 3 general drug to be in the competitive advantage of domain of natural plant medicine.